| Title |
Vitamin D for the management of multiple sclerosis
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2010
|
| DOI | 10.1002/14651858.cd008422.pub2 |
| Pubmed ID | |
| Authors |
Vanitha A Jagannath, Zbys Fedorowicz, G V Asokan, Edward W Robak, Liz Whamond |
| Abstract |
Multiple sclerosis is a disease of the central nervous system characterized by demyelination of the nerve sheaths which can result in varying levels of disability. Disease occurrence and progression are considered by some to be associated with low serum levels of vitamin D. Studies investigating vitamin D supplementation in MS patients have illustrated a noticeable improvement in the course of the disease. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 67% |
| Canada | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Scientists | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | <1% |
| United Kingdom | 1 | <1% |
| Mexico | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 126 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 21 | 16% |
| Student > Master | 20 | 15% |
| Researcher | 15 | 11% |
| Student > Ph. D. Student | 12 | 9% |
| Student > Doctoral Student | 11 | 8% |
| Other | 37 | 28% |
| Unknown | 15 | 11% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 66 | 50% |
| Nursing and Health Professions | 14 | 11% |
| Agricultural and Biological Sciences | 10 | 8% |
| Neuroscience | 5 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 2% |
| Other | 12 | 9% |
| Unknown | 21 | 16% |
Attention Score in Context
This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 February 2023.
All research outputs
#1,469,380
of 25,655,374 outputs
Outputs from Cochrane database of systematic reviews
#3,139
of 13,151 outputs
Outputs of similar age
#7,211
of 192,447 outputs
Outputs of similar age from Cochrane database of systematic reviews
#16
of 114 outputs
Altmetric has tracked 25,655,374 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,151 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.0. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,447 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 114 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.